The technology will allow Carlsmed to deliver its aprevo personalized spinal fusion implants to hospitals in fewer than 10 days, according to a Nov. 6 news release from the company.
Reduced lead times will make the implants more readily available by shortening scheduling windows, the release said.
Carlsmed’s device portfolio is indicated for use in lumbar spine fusion surgery. The launch of aprevo for cervical fusions is expected by the end of 2025.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.